CStone Pharmaceuticals (HK:2616)
:2616
Want to see HK:2616 full AI Analyst Report?
Comparison Results
CStone Pharmaceuticals
HK$5.34
HK$12.15B
-15.04
126.47%
2 Buy
0 Hold
0 Sell
Moderate Buy
Alphamab Oncology
HK$11.90
HK$8.33B
-15.87
12.35%
1 Buy
0 Hold
0 Sell
Moderate Buy
HBM Holdings Ltd.
HK$12.08
HK$10.47B
13.52
20.31%
2 Buy
0 Hold
0 Sell
Moderate Buy
Jiangsu Recbio Technology Co., Ltd. Class H
HK$4.18
HK$3.87B
-3.21
-43.03%
―
Abbisko Cayman Limited
HK$13.02
HK$7.24B
―
15.47%
3 Buy
0 Hold
0 Sell
Strong Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$7.01
HK$3.93B
424.16
-37.92%
―
Performance Comparison
HK:2616
CStone Pharmaceuticals
7.70
4.04
110.38%
HK:9966
Alphamab Oncology
8.55
-0.43
-4.79%
HK:2142
HBM Holdings Ltd.
11.79
2.09
21.55%
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
5.15
-3.91
-43.16%
HK:2256
Abbisko Cayman Limited
10.00
1.19
13.51%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
6.32
-4.68
-42.55%